Commercial or Open Source Closed Loop Impact on Pregnancy Study
Part of paid clinical trials in San Francisco, California.
- Sponsor
- University of California, San Francisco
- Study ID
- NCT06654713
- Status
- Recruiting
Conditions
- Insulin Dependent Diabetes
- Pregnancy Related
- Pregnancy, High Risk
- Type 1 Diabetes
Eligibility Criteria
- Sex
- FEMALE
- Age
- 18 Years - N/A
- Healthy Volunteers
- Not accepted
Interventions
- Commercial AID system — OTHERAID system that is commercially available and FDA approved for use
- Open source AID system — OTHERAID system that uses unregulated open-source software to customize an insulin delivery algorithm to connect an insulin pump to a continuous glucose monitor
Study Details
The goal of this observational study is to better understand what happens when pregnant people with type 1 diabetes (T1D) use automated insulin delivery (AID) systems. The main questions this study aims to answer are: * What are the maternal and neonatal outcomes with AID system use in pregnancy? * What are the glycemic outcomes with AID system use in pregnancy? * What are the behavioral and emotional outcomes with AID system use in pregnancy? Researchers will compare pregnant people who use commercial AID systems and pregnant people who use open source AID systems to see if outcomes are different with these different types of systems. Participants will be asked to remotely share their AID system data with the research team; complete online surveys regarding behavioral and emotional health; and sign an authorization to release health information to allow the research team to access medical records.
Key Dates
- Start date
- Mar 13, 2025
- Status verified
- May 2025
- Primary completion
- Dec 31, 2029
- Completion
- Dec 31, 2029
Study Design
- Enrollment
- 1,000 participants (estimated)
Arms
- Arm: Commercial AID systemPregnant individuals with type 1 diabetes (T1D) using commercially available automated insulin delivery (AID) systems for glycemic management in pregnancy
- Arm: Open source AID systemPregnant individuals with type 1 diabetes T1D) using open source automated insulin delivery (AID) systems (also known as do-it-yourself AID systems or hacked AID systems) for glycemic management in pregnancy
Primary Outcome Measure
Large for gestational age (LGA) [ Time Frame: At delivery ]
Central Contacts
- Primary Investigator(415) 307-9319
Locations (1)
| Facility | City | State | ZIP | Site coordinators |
|---|---|---|---|---|
| University of California, San Francisco | San Francisco | California | 94158 |
Find similar trials in San Francisco, CA
Related Studies
- POWERMOM, A Healthy Pregnancy Research CommunityRecruiting · Scripps Translational Science Institute · La Jolla, California
- Safety Study for Prospective Assessment of Pregnancy Outcomes in Patients Treated With TildrakizumabRecruiting · Sun Pharmaceutical Industries Limited · San Diego, California
- Compliant Analysis of Patient Samples and DataRecruiting · Sequenom, Inc. · San Diego, California
- Use of CGM in Kidney Transplant RecipientsRecruiting · University of California, Davis · Sacramento, California